RecallDepth
Class III Terminated

Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 300 mg, a) 90-count bottle (NDC 68001-264-05), b) 500-count bottle (NDC 68001-264-03) , Rx only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India For BluePoint Laboratories

Company
Amerisource Health Services
Recall Initiated
October 27, 2016
Posted
November 23, 2016
Recall Number
D-0137-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 15,409 bottles b) 5,128 bottles
Firm Location
Columbus, OH, United States

Reason for Recall

Failed Dissolution Specifications: The firm was notified that there was a dissolution out of specification result on the 6 month stability samples.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: a) M601509, Exp 3/31/2018; M606506, Exp 4/30/2018; b) M601510, Exp 3/31/2018; M604444, Exp 4/30/2018; M606515, Exp 4/30/2018.

More recalls by Amerisource Health Services

View all recalls by this company →

Other recent Class III Drug recalls